![Awakn Life Sciences Corporation (QB)](/common/images/company/NO_AWKNF.png)
Awakn Life Sciences Corporation (QB) (AWKNF)
USOTC
Year End January 30 2024 | 2022 | 2023 | 2024 |
---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -463.816 | -162.236 | -206.725 |
Return on Equity (%) | -1054.978 | -614.795 | 646.358 |
Return on Invested Capital (%) | -1771.714 | 13302.899 | 392.494 |
Operating Margin (%) | -6892.797 | -627.692 | -474.758 |
Net Profit Margin (%) | -6756.78 | -611.505 | -493.52 |
Book Value Per Share | 0.082 | -0.003 | -0.04 |
Earnings Per Share | -0.641 | -0.282 | -0.131 |
Cash Per Share | 0.065 | 0.017 | 0.01 |
Working Capital Per Share | 0.01 | -0.046 | -0.04 |
Operating Profit Per Share | 0.01 | 0.046 | 0.027 |
EBIT Per Share | -0.662 | -0.297 | -0.131 |
EBITDA Per Share | -0.662 | -0.297 | -0.131 |
Free Cash Flow Per Share | -0.579 | -0.297 | -0.139 |
Year End January 30 2024 | 2022 | 2023 | 2024 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Shares Outstanding | 24.89M | 32.48M | 39.09M |
Market Cap | 2.83M |
Price to Earnings Ratio | -0.55 |
Price to Sales Ratio | 2.69 |
Price to Cash Ratio | 6.93 |
Price to Book Ratio | -1.85 |
Dividend Yield | - |
Shares Outstanding | 40.38M |
Average Volume (1 week) | 1.02k |
Average Volume (1 Month) | 13.89k |
52 Week Change | -56.25% |
52 Week High | 0.26 |
52 Week Low | 0.0422 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.